11-58839575-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The ENST00000287275.6(GLYATL2):ā€‹c.38T>Cā€‹(p.Leu13Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,611,840 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00015 ( 0 hom., cov: 32)
Exomes š‘“: 0.00010 ( 0 hom. )

Consequence

GLYATL2
ENST00000287275.6 missense

Scores

4
7
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.20
Variant links:
Genes affected
GLYATL2 (HGNC:24178): (glycine-N-acyltransferase like 2) Enables glycine N-acyltransferase activity. Involved in long-chain fatty acid catabolic process; medium-chain fatty acid catabolic process; and monounsaturated fatty acid catabolic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GLYATL2NM_145016.4 linkuse as main transcriptc.38T>C p.Leu13Pro missense_variant 2/6 ENST00000287275.6 NP_659453.3
GLYATL2XM_017017337.3 linkuse as main transcriptc.38T>C p.Leu13Pro missense_variant 3/7 XP_016872826.1
GLYATL2XM_017017338.3 linkuse as main transcriptc.38T>C p.Leu13Pro missense_variant 2/6 XP_016872827.1
GLYATL2XM_047426545.1 linkuse as main transcriptc.-45-1207T>C intron_variant XP_047282501.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GLYATL2ENST00000287275.6 linkuse as main transcriptc.38T>C p.Leu13Pro missense_variant 2/61 NM_145016.4 ENSP00000287275 P1
GLYATL2ENST00000532258.1 linkuse as main transcriptc.38T>C p.Leu13Pro missense_variant 3/71 ENSP00000434277 P1
GLYATL2ENST00000533636.1 linkuse as main transcriptn.61-1207T>C intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000121
AC:
30
AN:
248432
Hom.:
0
AF XY:
0.000141
AC XY:
19
AN XY:
134830
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000418
Gnomad NFE exome
AF:
0.000168
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000103
AC:
150
AN:
1459494
Hom.:
0
Cov.:
28
AF XY:
0.000127
AC XY:
92
AN XY:
726106
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000375
Gnomad4 NFE exome
AF:
0.000107
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152346
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000106
Hom.:
0
Bravo
AF:
0.0000793
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.000174
AC:
21

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 02, 2023The c.38T>C (p.L13P) alteration is located in exon 2 (coding exon 1) of the GLYATL2 gene. This alteration results from a T to C substitution at nucleotide position 38, causing the leucine (L) at amino acid position 13 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.83
BayesDel_addAF
Uncertain
0.021
T
BayesDel_noAF
Uncertain
0.060
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T;T
Eigen
Benign
0.14
Eigen_PC
Benign
-0.064
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.66
.;T
M_CAP
Benign
0.0047
T
MetaRNN
Uncertain
0.63
D;D
MetaSVM
Benign
-0.91
T
MutationAssessor
Pathogenic
3.2
M;M
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-6.3
D;D
REVEL
Uncertain
0.30
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
1.0
D;D
Vest4
0.84
MVP
0.40
MPC
0.12
ClinPred
0.51
D
GERP RS
4.4
Varity_R
0.80
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140644520; hg19: chr11-58607048; API